Skip to content

CAFFE CON LATTE

Active Private limited companyfounded 2007active for 19 yearsVoorstraat 140, 1070 AnderlechtKBO/BCE: BE 0887.163.978

Board

2 directors, last change in 2024
Director (not named in the articles)
in office according to the deed of 03-01-2024 term without a fixed end
earlier director, until 26-03-2024
listed in the 2025 annual accounts, filed on 25-02-2026
Director (not named in the articles), permanent representative
in office according to the deed of 03-01-2024 term without a fixed end
earlier director, until 03-01-2024
listed in the 2025 annual accounts, filed on 25-02-2026
Permanent representatives 1
Permanent representative, for
in office according to the deed of 03-01-2024

Office holders in the KBO →

Mandates through the years

3 names, the dashed line is today

Director (not named in the articles)

Director (not named in the articles)

Director (not named in the articles)
BoardEarliermandate already running before its first mentionend not dated
Mandates as a list
    • Director (not named in the articles), since before 30-09-2021
    • Director, until 03-01-2024
    • Director (not named in the articles), since before 30-09-2021
    • Director, until 03-01-2024
    • Director, until 26-03-2024
    • Director (not named in the articles), from before 26-03-2024, no longer listed in the 2025 annual accounts

Control

Capital

Contribution
€65,040
Source
2025 annual accounts

Articles of association

deed of 26-03-2024 (in Dutch)
Board ruleThese rules set how the board is made up, meets and takes decisions.
At least 1 director
Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
1 December at 19:00

Capital transactions

Capital over time
  1. 03-01-2024 Converted to unavailable equity
  2. 03-01-2024 Converted to available equity
  3. 17-07-2013 Capital reduction of €100,000 · to €65,040 · “zonder vernietiging van aandelen maar met vermindering naar evenredigheid van de fractiewaarde van alle aandelen in het maatschappelijk vermogen”

Next steps